Fagotti, Anna
 Distribuzione geografica
Continente #
NA - Nord America 15.751
AS - Asia 13.888
EU - Europa 11.641
SA - Sud America 2.762
AF - Africa 375
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 17
Totale 44.477
Nazione #
US - Stati Uniti d'America 15.243
SG - Singapore 6.844
CN - Cina 2.724
DE - Germania 2.591
BR - Brasile 2.264
IT - Italia 2.081
SE - Svezia 1.758
VN - Vietnam 1.279
FR - Francia 1.038
NL - Olanda 823
IN - India 727
IE - Irlanda 623
UA - Ucraina 537
GB - Regno Unito 515
PL - Polonia 476
ID - Indonesia 420
FI - Finlandia 377
HK - Hong Kong 358
JP - Giappone 354
RU - Federazione Russa 288
BD - Bangladesh 276
CA - Canada 218
AR - Argentina 185
MX - Messico 165
TR - Turchia 150
IQ - Iraq 144
ZA - Sudafrica 99
KR - Corea 98
ES - Italia 89
AT - Austria 77
EC - Ecuador 77
BE - Belgio 75
PK - Pakistan 61
SA - Arabia Saudita 56
CI - Costa d'Avorio 52
CZ - Repubblica Ceca 52
PH - Filippine 51
CO - Colombia 50
MA - Marocco 48
VE - Venezuela 45
KE - Kenya 44
UZ - Uzbekistan 42
CH - Svizzera 41
CL - Cile 41
IR - Iran 38
PY - Paraguay 35
EG - Egitto 34
AU - Australia 29
JO - Giordania 27
LT - Lituania 26
RO - Romania 26
PE - Perù 25
MY - Malesia 24
IL - Israele 23
UY - Uruguay 22
AE - Emirati Arabi Uniti 21
JM - Giamaica 21
KZ - Kazakistan 21
OM - Oman 21
TN - Tunisia 19
HN - Honduras 18
AZ - Azerbaigian 17
PT - Portogallo 16
DZ - Algeria 15
HU - Ungheria 15
AL - Albania 14
PA - Panama 14
GR - Grecia 13
KG - Kirghizistan 13
TT - Trinidad e Tobago 13
BZ - Belize 12
ET - Etiopia 12
NP - Nepal 12
BG - Bulgaria 11
BO - Bolivia 11
DO - Repubblica Dominicana 11
HR - Croazia 11
LB - Libano 10
NZ - Nuova Zelanda 10
SN - Senegal 10
TW - Taiwan 10
CR - Costa Rica 9
DK - Danimarca 9
EU - Europa 9
LV - Lettonia 9
MD - Moldavia 9
NI - Nicaragua 9
RS - Serbia 8
AM - Armenia 7
LK - Sri Lanka 7
NG - Nigeria 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
AO - Angola 6
BH - Bahrain 6
GT - Guatemala 6
MN - Mongolia 6
NO - Norvegia 6
LA - Repubblica Popolare Democratica del Laos 5
XK - ???statistics.table.value.countryCode.XK??? 5
Totale 44.373
Città #
Singapore 3.860
Chandler 2.054
San Jose 1.821
Ashburn 1.575
Amsterdam 745
Beijing 620
Dublin 615
Rome 476
New York 462
Warsaw 420
Ho Chi Minh City 403
San Mateo 401
Los Angeles 389
Jakarta 377
Lauterbourg 364
Frankfurt am Main 345
Hyderabad 333
Hanoi 330
Tokyo 326
Hong Kong 320
Jacksonville 299
Wilmington 290
Hefei 282
Boston 268
Milan 265
Ann Arbor 258
Dallas 221
Nanjing 211
Houston 197
Princeton 184
São Paulo 184
Moscow 181
Woodbridge 181
Helsinki 166
The Dalles 164
Fairfield 159
Marseille 159
Munich 159
Dearborn 148
Santa Clara 146
Seattle 129
Cattolica 126
Boardman 124
Chicago 113
Council Bluffs 112
Buffalo 110
St Louis 106
Nürnberg 105
Tukwila 100
Redwood City 99
Lawrence 97
Rio de Janeiro 91
Orem 88
Seoul 87
Nuremberg 86
London 76
Kent 75
Da Nang 74
Atlanta 71
Brooklyn 68
Brussels 68
Nanchang 66
Paris 65
Shanghai 65
Lappeenranta 61
Toronto 60
Johannesburg 57
Haiphong 56
Bremen 55
Chennai 55
Düsseldorf 54
Hangzhou 54
Mountain View 54
Belo Horizonte 53
Abidjan 52
Phoenix 52
San Francisco 52
Mexico City 51
Montreal 51
Izmir 50
Denver 49
Kunming 49
Vienna 49
Baghdad 48
Brasília 48
Guangzhou 47
Cambridge 44
Norwalk 44
Dhaka 43
Turku 43
Zhengzhou 43
Leawood 41
Nairobi 40
Tashkent 39
Augusta 38
Manchester 38
Stockholm 38
Naples 37
Poplar 37
Fuzhou 36
Totale 24.277
Nome #
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team 942
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 536
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 376
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 349
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 305
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 293
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 288
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 231
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 229
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 226
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 220
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 213
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 212
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 211
Delaying surgery for patients with a previous SARS-CoV-2 infection 202
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 198
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 195
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 194
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 191
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 189
Urologic surgery in gynecologic oncology: a large single-institution experience 187
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 183
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 183
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 179
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 178
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 178
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 177
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 174
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 173
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 170
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 168
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 168
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 166
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 165
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 162
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 161
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 160
Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery 160
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 157
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 156
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 156
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 155
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 154
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 154
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 153
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 152
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 150
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 147
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 144
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 144
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 142
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 142
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 142
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 141
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 140
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 139
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 138
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 137
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 136
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 136
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 136
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 136
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 136
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 135
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 135
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 135
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 135
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 134
Droplet digital PCR for large genomic rearrangements detection: A promising strategy in tissue BRCA1 testing 134
Laparoscopic Ovarian Transposition with Extraperitonealization of the Infundibulopelvic Ligament for Cervical Cancer in Ten Steps 134
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 133
Surgical treatment of “large uterine masses” in pregnancy: A single-center experience 133
Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study 132
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 132
Targeting the hallmarks of ovarian cancer: The big picture 132
Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer 131
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 131
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 131
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 131
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 130
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 130
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 130
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) 130
Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis 130
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: A performance evaluation 129
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 129
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 128
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 128
BRCA testing delay during the COVID-19 pandemic: How to act? 128
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 127
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 126
BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score 126
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 126
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 126
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 126
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 126
Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation 126
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 125
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma 125
Totale 18.060
Categoria #
all - tutte 194.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 0 0 0 0 0 64
2021/20222.584 172 118 31 255 103 67 97 431 123 151 447 589
2022/20235.646 747 716 452 765 384 729 274 401 689 98 244 147
2023/20243.296 118 886 103 287 102 372 225 125 74 193 351 460
2024/20257.133 157 134 528 235 516 295 292 304 1.036 944 1.496 1.196
2025/202620.410 2.673 534 1.159 2.101 3.521 2.193 3.160 1.011 1.365 1.375 796 522
Totale 45.675